Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 AUD | +2.56% | +11.11% | -45.95% |
05-08 | Radiopharm Theranostics to be Featured in Healthcare Events Hosted by B. Riley Securities | MT |
02-29 | Radiopharm Theranostics Doses First Patient in Pancreatic Cancer Imaging Study | MT |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Radiopharmaceutical Products
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 12/09/21 | |
Antje Wegener
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gitasha Chand
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/21 |
Sherin Al-Safadi
CTO | Chief Tech/Sci/R&D Officer | - | 23/07/23 |
David Mozley
CTO | Chief Tech/Sci/R&D Officer | - | - |
Scot Harper
CTO | Chief Tech/Sci/R&D Officer | 67 | 30/11/21 |
Vittorio Puppo
COO | Chief Operating Officer | - | 31/05/22 |
Levente Meszaros
PRN | Corporate Officer/Principal | - | 31/12/21 |
Nathan Jong
SEC | Corporate Secretary | - | - |
Thomas Tulip
PRN | Corporate Officer/Principal | 71 | 31/08/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Hopper
CHM | Chairman | 68 | 10/02/21 |
Leila Alland
BRD | Director/Board Member | 61 | 05/06/22 |
Chief Executive Officer | - | 12/09/21 | |
Ian Turner
BRD | Director/Board Member | - | - |
Hester Larkin
BRD | Director/Board Member | - | 02/02/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 371,639,096 | 274,806,210 ( 73.94 %) | 0 | 73.94 % |
Company contact information
Sector
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.95% | 11.64M | |
+30.65% | 695B | |
+26.51% | 568B | |
-4.63% | 361B | |
+19.60% | 330B | |
+3.79% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+7.87% | 168B |
- Stock Market
- Equities
- RAD Stock
- Company Radiopharm Theranostics Limited